AxoGen
AXGN
55.75
-0.60
-1.06%
AxoGen
US · AXGN
#2714 by market cap
Listed 1970
55.75
-0.60
-1.06%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 11 analysts
Buy
Avg price target 58.18 +4.4%
Price target rangecurrent 55.75
Low48.00
Avg58.18
High65.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-12 | CCORF | -- | Buy | 60.00 |
| 2026-11-10 | Lake Street | -- | Buy | 60.00 |
| 2026-11-09 | CCORF | -- | Buy | 60.00 |
| 2026-10-29 | CCORF | -- | Buy | 60.00 |
| 2026-10-29 | Mizuho Securities | -- | Buy | 65.00 |
| 2026-10-29 | BofA Securities | -- | Buy | 62.00 |
| 2026-10-29 | Truist Financial | -- | Buy | 60.00 |
| 2026-10-29 | Leerink Partners | -- | Buy | 56.00 |
| 2026-10-29 | Lake Street | -- | Buy | 58.00 |
| 2026-10-29 | H.C. Wainwright | -- | Buy | 56.00 |
| 2026-10-29 | Barclays | -- | Buy | 60.00 |
| 2026-10-28 | Jefferies | -- | Buy | 60.00 |
| 2026-10-23 | Barclays | -- | Buy | 50.00 |
| 2026-10-12 | BofA Securities | -- | Buy | 52.00 |
| 2026-10-12 | Leerink Partners | -- | Buy | 52.00 |
| 2026-10-06 | Barclays | -- | Buy | 55.00 |
| 2026-10-05 | CCORF | -- | Buy | 55.00 |
| 2026-10-05 | Lake Street | -- | Buy | 55.00 |
| 2026-10-02 | Wells Fargo | -- | Buy | 48.00 |
| 2026-10-02 | Lake Street | -- | Buy | 55.00 |
| 2026-10-01 | Truist Financial | -- | Buy | 53.00 |
| 2026-09-30 | Lake Street | -- | Buy | 55.00 |
| 2026-09-29 | CCORF | -- | Buy | 55.00 |
| 2026-09-29 | Truist Financial | -- | Buy | -- |
| 2026-09-29 | Jefferies | -- | Buy | 55.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-28 | -- | ±22.89% | +31.47% (beat) |
| 2026/Q2 | 2026-07-29 | -- | ±15.67% | +0.53% (in line) |
| 2026/Q1 | 2026-04-28 | -- | ±15.36% | +6.60% (in line) |
| 2025/Q4 | 2026-02-24 | -- | ±15.69% | -8.14% (in line) |
| 2025/Q3 | 2025-10-29 | -- | ±15.40% | +23.06% (beat) |
| 2025/Q2 | 2025-08-05 | -- | ±26.35% | +9.32% (in line) |
| 2025/Q1 | 2025-05-08 | -- | ±16.21% | -23.18% (beat) |
| 2024/Q4 | 2025-02-25 | -- | ±19.77% | +11.66% (in line) |
| 2024/Q3 | 2024-11-07 | -- | ±23.27% | -13.44% (in line) |
| 2024/Q2 | 2024-08-08 | -- | -- | +35.10% |
| 2024/Q1 | 2024-05-02 | -- | ±14.48% | -10.37% (in line) |
| 2023/Q4 | 2024-03-05 | -- | ±14.92% | -15.11% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
AxoGen discussion 0 comments